| scholarly article | Q13442814 |
| P2093 | author name string | M Diculescu | |
| A Lupu | |||
| C L Constantinescu | |||
| C Tieranu | |||
| P2860 | cites work | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease | Q22251082 |
| Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey | Q24816756 | ||
| Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 | Q28943305 | ||
| Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model | Q34790990 | ||
| Unusual toxicities with TNF inhibition: heart failure and drug-induced lupus. | Q35955276 | ||
| Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women | Q36539788 | ||
| Drug-induced lupus due to anti-tumor necrosis factor alpha agents | Q36989060 | ||
| Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic | Q37406698 | ||
| Enteropathic spondyloarthropathy: a common genetic background with inflammatory bowel disease? | Q37495746 | ||
| Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review | Q37560336 | ||
| Adverse cutaneous reactions induced by TNF-alpha antagonist therapy | Q37623425 | ||
| Osteoarticular manifestations: specific treatments and/or treating intestinal disease? | Q38136960 | ||
| Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections | Q41917843 | ||
| Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease | Q42657495 | ||
| Inflammatory bowel disease-associated spondyloarthropathies | Q43122153 | ||
| A tale of two diseases: the history of inflammatory bowel disease | Q43697906 | ||
| Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database. | Q51136025 | ||
| A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. | Q55033683 | ||
| Autoimmune Diseases Induced by TNF-Targeted Therapies | Q56907567 | ||
| Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines | Q73065100 | ||
| Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis | Q80152463 | ||
| Drug-induced lupus | Q81349062 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 285-288 | |
| P577 | publication date | 2014-10-01 | |
| P1433 | published in | Current health sciences journal | Q26842456 |
| P1476 | title | TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD. | |
| P478 | volume | 40 |
| Q48140916 | Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature | cites work | P2860 |
Search more.